EN
Entera Bio Ltd.
ENTX · NASDAQ
$3.00 +1.69% (+$0.05)
1M -1.32%
Market Cap $147.9M
P/E Ratio -
Div. Yield -
ROE 147.19%
Bulios Fair Price
$1.53
49.0% downside
Trenutna cena
$3
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica ENTX trenutno precenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Weak
1/9Valuation
0 /100
Expensive P/B 20.35x
P/E N/A
P/FFO N/A
Growth
10 /100
Declining Rev. growth 32.07%
Book val. growth 3.68%
EPS growth N/A
Profitability
-
N/A Gross margin N/A
FCF margin N/A
Net margin N/A
Quality
0 /100
Poor ROIC 81.93%
Asset turnover 0.00x
ROE 147.19%
Debt
69 /100
Low Debt/Equity 0.06x
Int. coverage -5.20x
Current ratio 8.98x
Stability
58 /100
Moderate Beta 1.40x
Profitable years 0
EPS volatility 15.71%
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o ENTX
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Miranda J. Toledano
Employees
21
Headquarters
Jerusalem
Prihajajoči dogodki
13 NOV.
Earnings
Upcoming earnings report